Integrated Advisors Network LLC Has $279,000 Stake in iShares Biotechnology ETF (NASDAQ:IBB)

Integrated Advisors Network LLC decreased its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 19.0% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,919 shares of the financial services provider’s stock after selling 450 shares during the quarter. Integrated Advisors Network LLC’s holdings in iShares Biotechnology ETF were worth $279,000 as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in the business. Jane Street Group LLC acquired a new stake in iShares Biotechnology ETF in the first quarter valued at $14,386,000. Cetera Investment Advisers lifted its stake in iShares Biotechnology ETF by 689.4% in the first quarter. Cetera Investment Advisers now owns 91,078 shares of the financial services provider’s stock valued at $12,498,000 after acquiring an additional 79,541 shares during the last quarter. State of Michigan Retirement System lifted its stake in iShares Biotechnology ETF by 150.0% in the second quarter. State of Michigan Retirement System now owns 125,000 shares of the financial services provider’s stock valued at $17,158,000 after acquiring an additional 75,000 shares during the last quarter. Aristides Capital LLC acquired a new stake in iShares Biotechnology ETF in the second quarter valued at $9,180,000. Finally, Sanctuary Advisors LLC acquired a new stake in iShares Biotechnology ETF in the second quarter valued at $8,118,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Up 1.8 %

Shares of IBB stock opened at $142.78 on Friday. The company has a fifty day moving average price of $145.02 and a two-hundred day moving average price of $140.37. iShares Biotechnology ETF has a one year low of $113.56 and a one year high of $150.57.

iShares Biotechnology ETF Announces Dividend

The business also recently announced a dividend, which was paid on Monday, September 30th. Stockholders of record on Wednesday, September 25th were paid a dividend of $0.2005 per share. The ex-dividend date of this dividend was Wednesday, September 25th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.